# Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

> **NCT04966013** · NA · COMPLETED · sponsor: **EmitBio Inc.** · enrollment: 216 (actual)

## Conditions studied

- COVID19

## Interventions

- **DEVICE:** RD-X19
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT04966013
- **Lead sponsor:** EmitBio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-17
- **Primary completion:** 2022-01-05
- **Final completion:** 2022-02-23
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04966013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04966013, "Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04966013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*